Form 8-K - Current report:
SEC Accession No. 0000927066-22-000075
Filing Date
2022-05-05
Accepted
2022-05-05 16:08:59
Documents
14
Period of Report
2022-05-05
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K dva-20220505.htm   iXBRL 8-K 36638
2 EX-99.1 dva-33122ex991.htm EX-99.1 570459
6 davitalogorgbfa75a.jpg GRAPHIC 32400
  Complete submission text file 0000927066-22-000075.txt   831401

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT dva-20220505.xsd EX-101.SCH 2059
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT dva-20220505_lab.xml EX-101.LAB 24229
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT dva-20220505_pre.xml EX-101.PRE 12748
8 EXTRACTED XBRL INSTANCE DOCUMENT dva-20220505_htm.xml XML 10817
Mailing Address 2000 16TH STREET DENVER CO 80202
Business Address 2000 16TH STREET DENVER CO 80202 310-536-2668
DAVITA INC. (Filer) CIK: 0000927066 (see all company filings)

EIN.: 510354549 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14106 | Film No.: 22896279
SIC: 8090 Services-Misc Health & Allied Services, NEC